UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002950
Receipt number R000003588
Scientific Title Phase I study using pulverized curcumin for pancreatic/biliary tract cancer patients who get resistant to gemcitabine-based chemotherapy
Date of disclosure of the study information 2010/12/01
Last modified on 2013/08/03 15:32:38

No. Disposal Last modified on Item of update
1 Insert 2009/12/28 16:54:32
2 Update 2010/04/26 16:25:46 Date of disclosure of the study information
3 Update 2010/06/28 09:55:02 Anticipated trial start date
4 Update 2010/10/27 16:29:29 Condition
Condition
Classification by specialty
Narrative objectives1
Narrative objectives1
Trial characteristics_1
Primary outcomes
5 Update 2010/10/27 16:31:52 Public title
Public title
Acronym
Acronym
6 Update 2010/10/27 16:32:54 Condition
7 Update 2010/10/27 16:46:35 Interventions/Control_1
Key inclusion criteria
Target sample size
8 Update 2010/10/27 16:50:29 Last name of contact person
Last name of contact person
Name of person sending information
Organization
Division name
Address
TEL
Institute
Institute
Organization1
Tel1
Email1
Date of disclosure of the study information
9 Update 2010/10/27 16:50:53 Anticipated trial start date
10 Update 2011/01/31 11:16:58 Public title
Public title
Acronym
Acronym
11 Update 2011/01/31 11:17:54 Basic objectives2
Trial characteristics_1
Developmental phase
Primary outcomes
Primary outcomes
12 Update 2011/01/31 11:18:30 Target sample size
13 Update 2011/01/31 11:19:33 Anticipated trial start date
14 Update 2011/01/31 11:21:49 Recruitment status
15 Update 2012/05/21 13:56:30 Recruitment status
16 Update 2013/08/03 15:31:36 Post marketing survey by drug manufacture etc., specified by Japanese law.
17 Update 2013/08/03 15:32:38 Recruitment status
Publication of results